Home/Recalls/FDA-Z-2296-2026
FDA DevicesClass II

Avanta Multi-Patient Administration Tube Sets (AVA 500 MPAT (Part 2 of 2)) used ...

Published: June 10, 2026Recall ID: Z-2296-2026Category: devicesCountry: US

Reason for Recall / Hazard

Supplier changes resulted in a fit issue with the Contrast Flow Control Valve (CFCV) interface on the Avanta Injector System. Multiple customer reports indicate that the stopcock cannot be reliably engaged with the CFCV snap interface. In instances where engagement is achieved through applied force, the connection is unstable, and the stopcock may disengage before or during contrast injection, leading to procedure interruption.

Product Description & Identification

Avanta Multi-Patient Administration Tube Sets (AVA 500 MPAT (Part 2 of 2)) used with the Medrad¿ Avanta Injection System; Catalog number: AVA 500 MPAT (Part 2 of 2); Affected material numbers: 87629007, 60729458, 86566648;

Affected Products

Avanta Multi-Patient Administration Tube Sets (AVA 500 MPAT (Part 2 of 2)) used with the Medrad¿ Avanta Injection System; Catalog number: AVA 500 MPAT (Part 2 of 2); Affected material numbers: 87629007, 60729458, 86566648;

Additional Source Details

FieldValue
CityIndianola
StatePA
Event id98881
Address 11 Bayer Dr
Code infoCatalog number: AVA 500 MPAT (Part 2 of 2) Affected material numbers: 87629007, 60729458, 86566648; Affected batch numbers: 251702, 252302, 252502, 252602, 252702, 252802, 253304, 253702, 253704, 253804, 254202, 254304, 254704, 254802;
Postal code15051-9702
Report date20260610
Product typeDevices
Product quantity11,300 units (1650 US, 9650 OUS)
Reason for recallSupplier changes resulted in a fit issue with the Contrast Flow Control Valve (CFCV) interface on the Avanta Injector System. Multiple customer reports indicate that the stopcock cannot be reliably engaged with the CFCV snap interface. In instances where engagement is achieved through applied force, the connection is unstable, and the stopcock may disengage before or during contrast injection, leading to procedure interruption.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260424
Initial firm notificationLetter
Center classification date20260603

Overview

  • Recalling FirmBayer Medical Care, Inc.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionWorldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, DE, FL, IA, IL, IN, KS, KY, LA, MA, MD, ME, MO, NC, NY, OH, OK, PA, SC, TN, TX, VA, WI and the countries of AE, BA, BE, CA, CH, CN, DE, DK, ES, FR, GB, HK, HR, IL, KW, MT, MX, NL, RO, RU, SE, ZA.
Official Agency Alert